Related Experiment Video
Updated: Apr 16, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Pan-Serotype Diagnostic for Foot-and-Mouth Disease Using the Consensus Antigen of Nonstructural Protein 3B
Alyssa K Van Dreumel1, Wojtek P Michalski2, Leanne M McNabb2
1CSIRO Australian Animal Health Laboratory, Geelong, Victoria, Australia School of Medicine, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
Abstract:
An amino acid consensus sequence for the seven serotypes of foot-and-mouth disease virus (FMDV) nonstructural protein 3B, including all three contiguous repeats, and its use in the development of a pan-serotype diagnostic test for all seven FMDV serotypes are described. The amino acid consensus sequence of the 3B protein was determined from a multiple-sequence alignment of 125 sequences of 3B. The consensus 3B (c3B) protein was expressed as a soluble recombinant fusion protein with maltose-binding protein (MBP) using a bacterial expression system and was affinity purified using amylose resin. The MBP-c3B protein was used as the antigen in the development of a competition enzyme-linked immunosorbent assay (cELISA) for detection of anti-3B antibodies in bovine sera. The comparative diagnostic sensitivity and specificity at 47% inhibition were estimated to be 87.22% and 93.15%, respectively. Reactivity of c3B with bovine sera representing the seven FMDV serotypes demonstrated the pan-serotype diagnostic capability of this bioreagent. The consensus antigen and competition ELISA are described here as candidates for a pan-serotype diagnostic test for FMDV infection.
Insights
A new consensus amino acid sequence for foot-and-mouth disease virus (FMDV) nonstructural protein 3B was developed. This sequence enables a pan-serotype diagnostic test for all seven FMDV serotypes.
Area of Science:
- Veterinary Virology
- Immunodiagnostics
- Molecular Biology
Background:
- Foot-and-mouth disease virus (FMDV) poses a significant threat to livestock globally.
- Accurate and broad-spectrum diagnostic tests are crucial for FMDV control.
- Existing diagnostics may not cover all seven FMDV serotypes effectively.
Purpose of the Study:
- To develop a consensus amino acid sequence for the FMDV nonstructural protein 3B.
- To create a pan-serotype diagnostic test capable of detecting antibodies against all seven FMDV serotypes.
- To evaluate the diagnostic performance of the developed assay.
Main Methods:
- Multiple-sequence alignment of 125 FMDV 3B protein sequences to determine consensus.
- Expression and purification of the consensus 3B (c3B) protein as a recombinant fusion protein (MBP-c3B).
- Development of a competition enzyme-linked immunosorbent assay (cELISA) using MBP-c3B as the antigen.
Main Results:
- The consensus 3B (c3B) protein was successfully expressed and purified.
- The cELISA demonstrated high diagnostic performance: 87.22% sensitivity and 93.15% specificity.
- The MBP-c3B antigen showed reactivity with sera from all seven FMDV serotypes, confirming pan-serotype capability.
Conclusions:
- The developed consensus antigen (c3B) is a promising bioreagent for FMDV diagnostics.
- The competition ELISA using c3B shows potential as a pan-serotype diagnostic test for FMDV infection.
- This approach offers a unified strategy for detecting FMDV across all its serotypes.
More Related Videos
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022